These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study]. Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R Encephale; 2001; 27(4):373-6. PubMed ID: 11686060 [TBL] [Abstract][Full Text] [Related]
28. ERPs in schizophrenia: effects of antipsychotic medication. Ford JM; White PM; Csernansky JG; Faustman WO; Roth WT; Pfefferbaum A Biol Psychiatry; 1994 Aug; 36(3):153-70. PubMed ID: 7948453 [TBL] [Abstract][Full Text] [Related]
29. The importance of polysomnography in the evaluation of prolonged disorders of consciousness: sleep recordings more adequately correlate than stimulus-related evoked potentials with patients' clinical status. de Biase S; Gigli GL; Lorenzut S; Bianconi C; Sfreddo P; Rossato G; Basaldella F; Fuccaro M; Corica A; Tonon D; Barbone F; Valente M Sleep Med; 2014 Apr; 15(4):393-400. PubMed ID: 24508049 [TBL] [Abstract][Full Text] [Related]
30. Visual, long-latency auditory and brainstem auditory evoked potentials in migraine: relation to pattern size, stimulus intensity, sound and light discomfort thresholds and pre-attack state. Sand T; Vingen JV Cephalalgia; 2000 Nov; 20(9):804-20. PubMed ID: 11167910 [TBL] [Abstract][Full Text] [Related]
31. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)]. Obermair W; Pöldinger W Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440 [TBL] [Abstract][Full Text] [Related]
33. A risk-benefit assessment of mirtazapine in the treatment of depression. Kasper S; Praschak-Rieder N; Tauscher J; Wolf R Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961 [TBL] [Abstract][Full Text] [Related]
34. Amplitudes of somatosensory evoked potentials reflect cortical hyperexcitability in antidepressant-induced myoclonus. Förstl H; Pohlmann-Eden B Neurology; 1990 Jun; 40(6):924-6. PubMed ID: 2345616 [TBL] [Abstract][Full Text] [Related]
35. Tobacco use is associated with reduced amplitude and intensity dependence of the cortical auditory evoked N1-P2 component. Jawinski P; Mauche N; Ulke C; Huang J; Spada J; Enzenbach C; Sander C; Hegerl U; Hensch T Psychopharmacology (Berl); 2016 Jun; 233(11):2173-2183. PubMed ID: 26983415 [TBL] [Abstract][Full Text] [Related]
36. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351 [TBL] [Abstract][Full Text] [Related]
37. The prognostic value of evoked responses from primary somatosensory and auditory cortex in comatose patients. Logi F; Fischer C; Murri L; Mauguière F Clin Neurophysiol; 2003 Sep; 114(9):1615-27. PubMed ID: 12948790 [TBL] [Abstract][Full Text] [Related]
38. [Can neurophysiologic tests differentiate between depression and dementia?]. Grapperon J; Bruschera D; Vidal F; Raoul Y Ann Med Psychol (Paris); 1994 Apr; 152(4):217-28. PubMed ID: 8092661 [TBL] [Abstract][Full Text] [Related]
39. Knowledge of stimulus timing attenuates human evoked cortical potentials. Schafer EW; Amochaev A; Russell MJ Electroencephalogr Clin Neurophysiol; 1981 Jul; 52(1):9-17. PubMed ID: 6166459 [TBL] [Abstract][Full Text] [Related]